Vaso-Occlusive Crises: Clinical Trials

4 trials for Vaso-Occlusive Crises, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Terminated 4
Phase 11Terminated 1

Follow Vaso-Occlusive Crises: new trials by email Literature Review of Vaso-Occlusive Crises trials Research Report on Vaso-Occlusive Crises

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Varespladib Infusion in Subjects With Sickle Cell Disease.
Varespladib, Placebo (Normal Saline) - Sickle Cell Disease, Vaso-occlusive Crisis
Phase 2TerminatedAnthera Pharmaceuticals22012-02-012014-03-04
Safety and Efficacy of Sodium Nitrite in Sickle Cell Disease
sodium nitrite injection, usp - Sickle Cell Disease
Phase 1 / Phase 2TerminatedChildren's Hospital Los Angeles52009-12-012017-10-17
Hydroxyurea and Magnesium Pidolate to Treat People With Hemoglobin Sickle Cell Disease
Hydroxyurea, Magnesium Pidolate, Placebo Pills and Placebo Liquid - Hemoglobin SC Disease
Phase 2TerminatedSt. Jude Children's Research Hospital442007-01-012013-01-18
Inhaled Nitric Oxide for Pediatric Painful Sickle Crisis
nitric oxide, oxygen - Sickle Cell Disease
Phase 2TerminatedBoston Children's Hospital182005-04-012023-02-23

Narrower conditions

Anemia, Sickle Cell (4)  ·  Acute Chest Syndrome (1)  ·  Hemoglobin SC Disease (1)

Broader conditions

Anemia (4)  ·  Anemia, Hemolytic (4)  ·  Anemia, Hemolytic, Congenital (4)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)  ·  Genetic Diseases, Inborn (4)  ·  Hematologic Diseases (4)  ·  Hemic and Lymphatic Diseases (4)  ·  Hemoglobinopathies (4)  ·  Lung Diseases (1)  ·  Respiration Disorders (1)  ·  Respiratory Tract Diseases (1)

Interventions

Hydroxyurea (1)  ·  Nitric Oxide (1)  ·  Oxygen (1)  ·  Pyrrolidonecarboxylic Acid (1)  ·  Saline Solution (1)  ·  Sodium Nitrite (1)  ·  varespladib (1)

Sponsors

Anthera Pharmaceuticals (1)  ·  Boston Children's Hospital (1)  ·  Children's Hospital Los Angeles (1)  ·  St. Jude Children's Research Hospital (1)

Countries

United States (4)

Top investigators

Debra Weiner, MD, PhD (1)  ·  Thomas Coates, MD (1)  ·  Winfred C. Wang, MD (1)

Results publications

PMID 21275961

NIH funding

U54HL070587 (1)